Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 8,000 | |||
5 mg | 在庫あり | ¥ 18,500 | |||
10 mg | 在庫あり | ¥ 29,500 | |||
25 mg | 在庫あり | ¥ 66,500 | |||
50 mg | 在庫あり | ¥ 104,500 | |||
100 mg | 在庫あり | ¥ 154,500 | |||
500 mg | 在庫あり | ¥ 328,500 |
説明 | DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research. |
In vitro |
DHODH-IN-23 (72 h) inhibits proliferation of acute myeloid leukemia cells.[1] DHODH-IN-23 (0.1-3 μM; 72 h) induces the expression of CDllb in THP-1 cells.[1] |
In vivo | DHODH-IN-23 (30 mg/kg; oral; twice daily for 21 days) exhibits anti-tumor activity in the MV411 xenograft mouse model.[1] |
分子量 | 441.88 |
分子式 | C24H21ClFNO4 |
CAS No. | 1346705-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 112.5 mg/mL (254.6 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DHODH-IN-23 1346705-53-0 Metabolism Dehydrogenase Inhibitor inhibitor inhibit